Cartesian Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cartesian Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2017 to Q3 2024.
  • Cartesian Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 365 %, a 26.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 365 -130 -26.3% Sep 30, 2024
Q2 2024 276 -267 -49.2% Jun 30, 2024
Q1 2024 269 -298 -52.6% Mar 31, 2024
Q4 2023 307 -194 -38.8% Dec 31, 2023
Q3 2023 495 +136 +37.8% Sep 30, 2023
Q2 2023 543 +295 +119% Jun 30, 2023
Q1 2023 567 +366 +182% Mar 31, 2023
Q4 2022 501 +317 +172% Dec 31, 2022
Q3 2022 359 +178 +98% Sep 30, 2022
Q2 2022 249 +52.6 +26.8% Jun 30, 2022
Q1 2022 201 -2.59 -1.27% Mar 31, 2022
Q4 2021 184 -30.4 -14.2% Dec 31, 2021
Q3 2021 181 -61 -25.2% Sep 30, 2021
Q2 2021 196 -33.3 -14.5% Jun 30, 2021
Q1 2021 204 +4.91 +2.47% Mar 31, 2021
Q4 2020 215 +31.7 +17.3% Dec 31, 2020
Q3 2020 242 +102 +72.3% Sep 30, 2020
Q2 2020 229 +79.6 +53.2% Jun 30, 2020
Q1 2020 199 +5.47 +2.83% Mar 31, 2020
Q4 2019 183 -80.4 -30.5% Dec 31, 2019
Q3 2019 141 -291 -67.5% Sep 30, 2019
Q2 2019 150 -600 -80% Jun 30, 2019
Q1 2019 194 -555 -74.1% Mar 31, 2019
Q4 2018 263 -441 -62.6% Dec 31, 2018
Q3 2018 432 -219 -33.7% Sep 30, 2018
Q2 2018 750 +99.1 +15.2% Jun 30, 2018
Q1 2018 749 -9.01 -1.19% Mar 31, 2018
Q4 2017 705 Dec 31, 2017
Q3 2017 651 Sep 30, 2017
Q2 2017 651 Jun 30, 2017
Q1 2017 758 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.